Acanthamoeba |
For keratitis/ophthalmic samples only |
Contact the Diagnostic Parasitology Laboratory at the London School of Hygiene and Tropical Medicine |
LSHTM |
Achromobacter |
Species identification, molecular typing and antimicrobial resistance |
H1, H2
|
AMRHAI |
Acinetobacter |
Species identification, molecular typing and antimicrobial resistance |
H1, H2
|
AMRHAI |
Actinomycetes (Aerobic) |
Antimicrobial susceptibility |
H1, H2
|
AMRHAI |
Actinomycetes (Aerobic) |
Identification and confirmation |
M1, H2
|
AMRHAI |
Adenoviruses (enteric) |
PCR |
E1 |
EVU |
Adenoviruses (respiratory) |
PCR |
E27 |
RVU |
Amoebae (excluding Acanthamoeba keratitis) |
Detection, identification and confirmation, serodiagnosis |
Contact National parasitology reference laboratory (NPRL) |
NPRL |
Anaerobes (bacteroides, clostridia, fusobacteria, actinomyces spp., other closely related genera) |
Identification |
Contact ARU
|
ARU |
Anthrax |
See Bacillus anthracis |
|
|
Antibiotic resistance surveys |
European antibiotic resistance surveillance scheme (EARSS) and surveillance of resistance |
H1 |
AMRHAI |
Antibiotic susceptibility testing |
New antimicrobials, susceptibility testing service, beta-lactamases, endocarditis |
H1, H2
|
AMRHAI |
Arboviruses (bunyaviridae, flaviviridae, togaviridae) |
Isolation, serology, PCR
|
P1 |
RIPL |
Aspergillus |
Identification and confirmation |
Y1 or Y2
|
Mycology RL |
Astrovirus |
RT-PCR
|
E1 |
EVU |
Astrovirus |
Genotyping |
Contact EVU
|
EVU |
Bacillus anthracis |
Identification and confirmation, PCR, serology, characterisation (phage, penicillin sensitivity) |
Contact RIPL lab |
RIPL |
Bacillus (other than B.anthracis) |
Identification |
L4 |
GBRU |
Bacillus (other than B.anthracis) |
Molecular typing |
L4 |
GBRU |
Bacillus (other than B.anthracis) |
Detection of emetic toxin gene by PCR
|
L4 |
GBRU |
Bacillus (other than B.anthracis) |
Antimicrobial susceptibility |
H1, H2
|
AMRHAI |
Bacterial Identification Service (BIDS) – isolates |
Isolate identification (unknown, atypical, fastidious, emerging bacteria) |
M1 |
AMRHAI |
Bacterial Identification Service (BIDS) – clinical samples |
Bacterial detection and species identification for culture-negative, unknown clinical samples from normally sterile sites |
M1 |
AMRHAI |
Blastomyces dermatidis |
Serology, identification and confirmation |
Y1 or Y2
|
MRL |
Bordetella spp. |
Identification |
R3 |
RVPBRU |
Bordetella spp. |
Antimicrobial susceptibility |
H1, H2
|
AMRHAI |
Bordetella pertussis |
Serology: anti-PT IgG antibodiesNot suitable for immune status |
R3 |
RVPBRU |
Bordetella pertussis |
Oral fluid: anti-PT IgG antibodies. NOT suitable for immune status |
Form distributed with kit |
RVPBRU |
Bordetella pertussis |
qPCR |
R3 |
RVPBRU |
Brucella spp. |
Serodiagnosis |
Y3 |
BRU |
Brucella spp. |
Speciation and characterisation |
Contact AHVLA laboratory, Weybridge |
BRU |
Burkholderia spp. |
Species identification, molecular typing and antimicrobial resistance |
H1, H2
|
AMRHAI |
Burkholderia pseudomallei |
Identification and antimicrobial resistance |
H1, H2
|
AMRHAI |
Candida spp. |
Identification and confirmation |
Y1 or Y2
|
Mycology RL |
Campylobacter |
Antibiotic susceptibility testing for gram negative GI pathogens |
L4 |
GBRU |
Campylobacter |
Identification |
L4 |
GBRU |
Chikungunya virus |
Serology, PCR
|
P1 |
RIPL |
Chlamydia (respiratory) |
Only available after discussion and prior agreement with RVPBRU C. pneumoniae, C. psittacci, C. abortus: PCR assay |
For urgent enquiries, contact RVPBRU
|
RVPBRU |
Chlamydia trachomatis |
C. trachomatis: LGV multiplex PCR
|
B7 |
CSU |
Clostridium difficile |
16S/23S PCR ribotyping, antibiotic susceptibility testing and toxin A and B assay on isolates |
Contact ARU
|
ARU |
Clostridium botulinum |
Detection and identification of C. botulinum from clinical, food or environmental samples by PCR and culture |
L4 |
GBRU |
Clostridium botulinum |
Detection of botulinum neurotoxins in clinical specimens or food |
L4, L7
|
GBRU |
Clostridium perfringens |
Identification of enterotoxigenic C. perfringens by PCR
|
L4 |
GBRU |
Clostridium perfringens |
Molecular typing |
L4 |
GBRU |
Clostridium perfringens |
Detection of C. perfringens enterotoxin in faeces by ELISA
|
L4 |
GBRU |
Clostridium perfringens |
C. perfringens Toxin (lethal toxins) typing by PCR
|
L4 |
GBRU |
Clostridium tetani |
Detection and identification of C. tetani by PCR and culture |
L4 |
GBRU |
Clostridium tetani |
Detection of C. tetani neurotoxin in serum (note: serum will be first tested for tetanus antibody levels by RVPBRU) |
L4 |
GBRU |
Clostridium tetani |
Tetanus immunity: serum antibodies |
R3 |
RVPBRU |
Coccidioides immitis |
Serology, identification and confirmation |
Y1 or Y2
|
Mycology RL |
Coronavirus |
Virus detection by PCR (sequencing) |
E16 |
RVU |
Coronavirus (SARS) |
Contact laboratory prior to collection of samples |
E16 |
RVU |
Coronavirus (SARS-CoV-2) |
Confirmatory testing |
V30 |
regional PHE |
Coronavirus (MERS-CoV) |
Contact laboratory prior to collection of samples |
E16 |
RVU |
Corynebacterium |
Molecular typing and antimicrobial resistance |
H1, H2
|
AMRHAI |
Corynebacterium diphtheriae |
C. diphtheriae and other potentially toxigenic corynebacteria: identification and toxin testing by PCR and Elek |
R3 |
RVPBRU |
Corynebacterium diphtheriae |
Diphtheria immunity: serum antibodies |
R3 |
RVPBRU |
Corynebacterium jeikeium |
C. jeikeium antimicrobial sensitivity |
H2 |
AMRHAI |
Crimean-Congo haemorrhagic fever |
Serology, PCR. Please contact lab before sending samples. |
P1 |
RIPL |
Cronobacter |
C. sakazakii: confirmation of identification, molecular typing and antimicrobial resistance |
H1, H2
|
AMRHAI |
Cystic Fibrosis (CF) pathogens |
Identification and molecular typing |
H2 |
AMRHAI |
Cystic Fibrosis (CF) pathogens |
Antimicrobial susceptibility |
H1, H2
|
AMRHAI |
Cryptococcus spp. |
Identification and confirmation |
Y1 or Y2
|
Mycology RL |
Cryptosporidium spp. |
Detection, identification and confirmation, typing |
Contact CRU
|
CRU |
Dengue virus |
Serology, PCR
|
P1 |
RIPL |
Dermatophytes |
Identification, confirmation |
Y1 or Y2
|
Mycology RL |
Diphtheria (see Corynebacterium diphtheriae) |
|
|
|
Ebola virus |
Serology, PCR. Please contact lab before sending samples. |
P1 |
RIPL |
Elizabethkingia.spp |
Identification, molecular typing and antimicrobial resistance |
H1, H2
|
AMRHAI |
Enterobacter spp. |
Molecular typing and antimicrobial resistance |
H1, H2
|
AMRHAI |
Enterococcus spp. |
Species identification, molecular typing and antimicrobial resistance |
H1, H2
|
AMRHAI |
Enterovirus |
RT-PCR
|
E1 |
EVU |
Enterovirus |
Virus culture |
Contact EVU
|
EVU |
Enterovirus |
Typing |
E1 |
EVU |
Escherichia |
Antibiotic susceptibility testing for gram negative GI pathogens |
L4 |
GBRU |
Escherichia |
E. coli (ACDP HG 2 only): molecular typing and antimicrobial resistance |
H1, H2
|
AMRHAI |
Escherichia |
Identification and typing |
L4 |
GBRU |
Escherichia |
E. coli O157: serodiagnostic service |
L5 |
GBRU |
Escherichia |
Detection and isolation from faeces |
L5 |
GBRU |
Francisella spp., including tularensis |
PCR, serology, isolation |
P1 |
RIPL |
Gram-negative bacteria non fermenter and fastidious organisms |
Molecular typing and antimicrobial resistance |
H1, H2
|
AMRHAI |
Gram-positive bacteria (except C.diphtheriae) |
Molecular typing and antimicrobial resistance |
H1, H2
|
AMRHAI |
Haemophilus |
Haemophilus spp. (excluding H. ducreyi): identification |
R3 |
RVPBRU |
Haemophilus |
H. influenzae: sero typing and capsular genotyping of H.influenzae |
R3 |
RVPBRU |
Haemophilus spp. and Aggregatibacter spp. |
Antimicrobial susceptibility |
H1, H2
|
AMRHAI |
Haemorrhagic fever viruses (filoviridae, arenaviridae, Bunyaviridae) |
Serology, PCR. Please contact lab before sending samples. |
P1 |
RIPL |
Hantavirus |
Serology, PCR. |
P1 |
RIPL |
Hendra virus |
Serology, PCR. Please contact lab before sending samples. |
P1 |
RIPL |
Helicobacter |
Antibiotic susceptibility testing for gram negative GI pathogens |
L4 |
GBRU |
Helicobacter |
H. pylori identification and antibiotic susceptibility |
L4,L5
|
GBRU |
Hepatitis A virus (HAV) |
RNA |
S1 |
BBVU |
Hepatitis A virus (HAV) |
Genotyping and phylogenetics |
S1 |
BBVU |
Hepatitis A virus (HAV) |
Anti-HAV IgG and IgM |
S1 |
CSU |
Hepatitis B virus (HBV) |
HBsAg detection |
S1 |
CSU |
Hepatitis B virus (HBV) |
HBsAg quantification |
S1 |
CSU |
Hepatitis B virus (HBV) |
HBsAg neutralisation |
S1 |
CSU |
Hepatitis B virus (HBV) |
HBeAg |
S1 |
CSU |
Hepatitis B virus (HBV) |
Anti-HBc |
S1 |
CSU |
Hepatitis B virus (HBV) |
Anti-HBc IgM |
S1 |
CSU |
Hepatitis B virus (HBV) |
Anti-HBs |
S1 |
CSU |
Hepatitis B virus (HBV) |
Anti-HBe |
S1 |
CSU |
Hepatitis B virus (HBV) |
DNA viral load |
S1 |
CSU |
Hepatitis B virus (HBV) |
Pre-core and BCP mutation screen |
S10 |
BBVU |
Hepatitis B virus (HBV) |
Surface mutation screen |
S10 |
BBVU |
Hepatitis B virus (HBV) |
Antiviral resistance |
S10 |
BBVU |
Hepatitis B virus (HBV) |
Genotyping and phylogenetics |
S10 |
BBVU |
Hepatitis C virus (HCV) |
Antibody confirmation and viral load |
S1 |
CSU |
Hepatitis C virus (HCV) |
Antibody confirmation (dried blood spots and oral fluid samples) |
S1 |
BBVU |
Hepatitis C virus (HCV) |
Viral load |
S1 |
CSU |
Hepatitis C virus (HCV) |
Viral load (sensitivity >15 IU/ml) Please contact lab prior to sample referral |
S1 |
CSU |
Hepatitis C virus (HCV) |
Qualitative RNA detection |
S1 |
BBVU |
Hepatitis C virus (HCV) |
Genotyping (NS5B sequencing): EDTA plasma |
S1 |
CSU |
Hepatitis C virus (HCV) |
Genotyping (NS5B sequencing): dried blood spots |
S1 |
BBVU |
Hepatitis C virus (HCV) |
Phylogenetics |
S1 |
BBVU |
Hepatitis C virus (HCV) |
HCV DAA genotypic resistance |
Contact AVU
|
AVU |
Hepatitis Delta virus (HDV) |
Anti-HDV IgG
|
S1 |
CSU |
Hepatitis Delta virus (HDV) |
Anti-HDV IgM |
S1 |
CSU |
Hepatitis Delta virus (HDV) |
RNA |
S1 |
BBVU |
Hepatitis E virus (HEV) |
Anti-HEV IgG
|
S1 |
CSU |
Hepatitis E virus (HEV) |
Anti-HEV IgM |
S1 |
CSU |
Hepatitis E virus (HEV) |
RNA |
S1 |
BBVU |
Hepatitis E virus (HEV) |
Genotyping, phylogenetics |
S1 |
BBVU |
Herpes simplex virus (HSV 1 and 2) |
Phenotypic drug resistance |
Contact AVU
|
AVU |
Herpes simplex virus (HSV 1 and 2) |
Intrathecal antibody testing |
S4 |
IDU |
Histoplasma capsulatum |
Serology, identification and confirmation |
Y1 or Y2
|
Mycology RL |
Histology slides |
Examination for the presence of fungi |
Y1 or Y2
|
Mycology RL |
HIV-1 and HIV-2 |
HIV 1, HIV-2 antibody screen, confirmation, typing |
S3 |
CSU |
HIV-1 and HIV-2 |
HIV 1, HIV-2 antibody screen, confirmation, typing (dried blood spots) |
S3 |
CSU |
HIV-1 and HIV-2 |
HIV 1, HIV-2 antibody screen, confirmation, typing, oral fluid (OraSure) |
S3 |
CSU |
HIV-1 and HIV-2 |
HIV-1 proviral DNA |
S3 |
CSU |
HIV-1 and HIV-2 |
HIV-1 RNA quantification (viral load) |
S3 |
CSU |
HIV-1 and HIV-2 |
HIV-1 p24 antigen with neutralisation |
S3 |
CSU |
HIV-1 and HIV-2 |
HIV-1 incidence testing (avidity) |
S3 |
CSU |
HIV-1 and HIV-2 |
HIV-1 genotypic resistance |
S9 |
AVU |
HIV-1 and HIV-2 |
HIV-1 proviral tropism testing |
S9 |
AVU |
HIV-1 and HIV-2 |
Detection of minority drug resistance mutants |
S9 |
AVU |
HIV-1 and HIV-2 |
HIV-1 sequencing and sequence comparison |
Contact AVU
|
AVU |
Human T-lymphotropic virus type I and Human T-lymphotropic virus type II (HTLV-I and II) |
HTLV antibody screen, confirmation, typing |
S5 |
CSU |
Human T-lymphotropic virus type I and Human T-lymphotropic virus type II (HTLV-I and II) |
HTLV type-specific PCR
|
S5 |
CSU |
Human herpesvirus 6 (HHV-6) |
Antibody testing |
E18 |
IDU |
Human herpesvirus 6 (HHV-6) |
PCR and genotyping |
E18 |
IDU |
Human herpesvirus 7 (HHV-7) |
Antibody testing |
E18 |
IDU |
Human herpesvirus 7 (HHV-7) |
PCR and genotyping |
E18 |
IDU |
Human herpesvirus 8 (HHV-8) |
Quantitative DNA PCR
|
S19 |
CSU |
Human metapneumovirus |
Virus detection by PCR andsequencing |
Contact RVU
|
RVU |
Hydatid disease or Echinococcosis |
Serology |
Contact NPRL
|
NPRL |
Identification of bacterial isolates with no national reference facility (unknowns, atypical, fastidious, emerging |
MALDI-TOF-MS, 16s ribosomal sequence analysis |
M1 |
AMRHAI |
Infection prevention and control |
testing |
Contact AMRHAI
|
AMRHAI |
Influenza |
Virus detection by multiplex PCR
|
E3 |
RVU |
Influenza |
Strain typing HAI |
E3 |
RVU |
Influenza |
Antibody response HAI |
E2 |
RVU |
Influenza |
Phenotypic drug resistance |
Contact RVU
|
RVU |
Influenza |
Genotypic drug resistance by pyrosequencing and SNP PCR
|
Contact RVU
|
RVU |
Influenza |
Genotypic drug resistance by gene sequencing |
Contact RVU
|
RVU |
Influenza (avian) |
Confirmation of regional laboratory H9 virus detection |
Contact RVU
|
RVU |
Influenza (avian) |
Antibody response |
Contact RVU
|
RVU |
JC virus (see Polyomavirus) |
Serology, PCR
|
E13 |
IDU |
Klebsiella spp. |
Molecular typing and antimicrobial resistance |
H1, H2
|
AMRHAI |
Lassa virus |
Serology, PCR. Please contact lab before sending samples. |
P1 |
RIPL |
Legionella |
L.pneumophila: in-house urinary antigen EIA assay (confirmation of sending lab testing results only) |
R1 |
RVPBRU |
Legionella |
L pneumophila PCR (from urinary antigen positive patients only) |
R1 |
RVPBRU |
Legionella |
Identification and epidemiological typing of clinical or outbreak associated isolates |
R1 |
RVPBRU |
Leuconostoc spp. |
Antimicrobial susceptibility |
H1, H2
|
AMRHAI |
Leptospira spp |
Isolation and confirmation, identification, serology |
Leptospirosis: request form |
NLS |
Listeria spp. |
Identification, serotyping and molecular typing of L.monocytogenes |
L4 |
GBRU |
Listeria spp. |
Species identification of Listeria |
L4 |
GBRU |
Listeria spp. |
Antimicrobial susceptibility |
H1, H2
|
AMRHAI |
Lyme disease |
Serology, PCR
|
P2 |
RIPL |
Malaria |
Blood film diagnosis, antigen detection, PCR, drug resistance markers |
Malaria report form |
Malaria RL |
Marburg virus |
Serology, PCR. Please contact lab before sending samples. |
P1 |
RIPL |
Measles |
IgG and IgM serology for recent infection |
E8 |
IDU |
Measles |
IgG antibody status |
E8 |
IDU |
Measles |
Intrathecal antibody testing |
E8 |
IDU |
Measles |
PCR |
E8 |
IDU |
Measles |
Same day testing |
E8 |
IDU |
Measles |
Plaque reduction neutralisation assay |
E8 |
IDU |
Measles |
Virus culture |
E8 |
IDU |
Middle East respiratory syndrome coronavirus (MERS-CoV) |
Contact laboratory prior to collection of specimens |
E16 |
RVU |
Molluscum contagiosum |
Electron microscopy |
E17 |
HPU |
Moulds |
Identification and confirmation, susceptibility testing |
Y1 or Y2
|
Mycology RL |
Methicillin-resistant staphylococcus aureus (MRSA) (see Staphylococcus) |
|
|
|
Mumps |
IgG and IgM serology for recent infection |
E8 |
IDU |
Mumps |
IgG antibody status |
E8 |
IDU |
Mumps |
PCR |
E8 |
IDU |
Mumps |
Virus culture |
E8 |
IDU |
Mycobacterium spp. |
Identification, genotyping, drug susceptibility, molecular diagnosis (eg PCR for rapid species identification and detection of resistance genes), molecular epidemiological studies, QuantiFERON®-TB Gold test |
N1, N4
|
NMRS-South |
Mycoplasma |
M.hominis and Ureaplasma spp.: PCR and/or culture |
R1 |
RVPBRU |
Mycoplasma |
Mycoplasma and ureaplasma: biochemical characterisation and molecular methods |
R1 |
RVPBRU |
Mycoplasma |
M. pneumoniae: PCR
|
R1 |
RVPBRU |
Mycoplasma |
M. genitalium: molecular detection of the adhesion MgPa gene |
B7 |
AMRHAI |
Mycoplasma |
Other species: culture, PCR and sequencing when relevant |
R1 |
RVPBRU |
Neisseria spp. |
N.gonorrhoeae: confirmation of identification by phenotypic and molecular methods |
B7 |
AMRHAI |
Neisseria spp. |
Susceptibility testing for third-generation cephalosporin and azithromycin antibiotics |
B2 |
AMRHAI |
Neisseria spp. |
Molecular confirmation of GC NAAT result |
B2 |
CSU |
Neisseria spp. |
Programme: Gonococcal resistance to antimicrobials surveillance programme (GRASP) |
Contact AMRHAI before sending samples |
AMRHAI |
Neisseria meningitidis |
Culture identification, molecular epidemiological studies, PCR, serology |
Meningococcal reference unit request form |
MRU |
Nipah and Hendra viruses |
PCR, isolation |
P1 |
RIPL |
Nocardia spp. |
Antimicrobial susceptibility |
H1, H2
|
AMRHAI |
Noroviruses |
RT-PCR
|
E6 |
EVU |
Noroviruses |
Genotyping |
E6 |
EVU |
Opportunistic Pathogens |
Molecular typing and antimicrobial resistance |
H1, H2
|
AMRHAI |
Orf |
Electron microscopy |
E17 |
HPU |
Pandoraea spp. |
Molecular typing and antimicrobial resistance |
H1, H2
|
AMRHAI |
Parainfluenza virus |
Virus detection by PCR (sequencing) |
Contact RVU
|
RVU |
Parasites, intestinal protozoa and helminths, blood and tissue protozoa and helminths |
|
Contact NPRL
|
NPRL |
Parvovirus B19 |
Serology (IgG and IgM) |
E9 |
IDU |
Parvovirus B19 |
PCR and genotyping |
E9 |
IDU |
Penicillium marneffei |
|
Y1 or Y2
|
Mycology RL |
Plasmodium spp. |
|
Malaria report form |
Malaria RL |
Polioviruses |
RT-PCR, genotyping, virus culture |
E1 |
EVU |
Polioviruses |
Intratypic neutralisation |
E1 |
EVU |
Polyomavirus JC |
Serology |
E13 |
IDU |
Polyomavirus JC |
PCR |
E13 |
IDU |
Polyomavirus JC |
Intrathecal antibody testing |
E13 |
IDU |
Pseudomonas spp. |
Molecular typing and antimicrobial susceptibility |
H1, H2
|
AMRHAI |
PVL (see staphylococcus) |
|
|
|
Q fever (Coxiella burnetii) |
|
P1 |
RIPL |
Rabies exposure |
Contact rabies clerk on 020 8327 6204 |
|
|
Rabies diagnosis |
Contact rabies clerk on 020 8327 6204 |
|
|
Ralstonia spp. |
Molecular typing and antimicrobial resistance |
H1, H2
|
AMRHAI |
Respiratory syncytial virus (RSV) |
Virus detection by multiplex PCR
|
Contact RVU
|
RVU |
Resistance mechanisms |
Molecular detection and confirmation |
H1, H2
|
AMRHAI |
Rickettsiae (typhus and spotted fever groups, scrub typhus group) |
|
P1 |
RIPL |
Rhinovirus |
Virus detection by PCR
|
Contact RVU
|
RVU |
Rotavirus |
RT-PCR
|
E1 |
EVU |
Rotavirus |
VP6 and NSP4 genotyping |
E1 |
EVU |
Rubella |
IgG and IgM serology for recent infection |
E8 |
IDU |
Rubella |
IgG antibody status |
E8 |
IDU |
Rubella |
PCR |
E8 |
IDU |
Rubella |
Virus culture |
E8 |
IDU |
Salmonella |
Antibiotic susceptibility testing for gram negative GI pathogens |
L4 |
GBRU |
Salmonella |
Identification and typing |
L4 |
GBRU |
Sapovirus |
RT-PCR
|
E1 |
EVU |
Severe acute respiratory syndrome (SARS) |
See coronavirus. Contact laboratory prior to collection of specimens |
E16 |
RVU |
Serratia |
Molecular typing and antimicrobial resistance |
H1, H2
|
AMRHAI |
Shigella |
Antibiotic susceptibility testing for gram negative GI pathogens |
L4 |
GBRU |
Shigella |
Identification and typing |
L4 |
GBRU |
Staphylococcus |
S.aureus: molecular typing |
H1, H2
|
AMRHAI |
Staphylococcus |
Staphylococcus coagulase negative: species identification and molecular typing |
H1, H2
|
AMRHAI |
Staphylococcus |
Antimicrobial susceptibility testing |
H1, H2
|
AMRHAI |
Staphylococcus |
Resistance gene detection |
H1, H2
|
AMRHAI |
Staphylococcus |
Toxin gene detection (including PVL) |
H1, H2
|
AMRHAI |
Staphylococcus |
Detection of staphylococcal enterotoxins A, B, C, D or E in foods or beverages. |
Contact laboratory |
GBRU |
Stenotrophomonas |
S.maltophilia: molecular typing and antimicrobial resistance |
H1, H2
|
AMRHAI |
Streptococcus |
Streptococcus spp. and related genera or Gram positive cocci: identification |
R1 |
RVPBRU |
Streptococcus |
S.pyogenes (Lancefield Group A) typing |
R1 |
RVPBRU |
Streptococcus |
S.agalactiae (Lancefield Group B) typing |
R1 |
RVPBRU |
Streptococcus |
Lancefield Group C and G typing |
R1 |
RVPBRU |
Streptococcus |
S. pneumoniae: serological typing |
R3 |
RVPBRU |
Streptococcus |
Antimicrobial susceptibility |
H1, H2
|
AMRHAI |
Tetanus |
Tetanus immunity: serum antibodies |
R3 |
RVPBRU |
Toxoplasma gondii |
Isolation, identification, culture collection, serology (for active infection) molecular diagnostics by PCR
|
Contact toxoplasma reference laboratory, Swansea |
TRL |
Treponema |
T. pallidum (syphilis): serological |
B3 |
CSU |
Treponema |
T.pallidum, Haemophilus ducreyi, Herpes Simplex Virus (HSV) complex (Genital ulcer disease): PCR
|
B3 |
CSU |
Unknown haemadsorbing agents |
Virus detection by PCR
|
Contact RVU
|
RVU |
Ureaplasma |
Refer to mycoplasma |
R1 |
RVPBRU |
Varicella-zoster virus (VZV) |
IgG serology |
E11 |
IDU |
Varicella-zoster virus (VZV) |
Intrathecal antibody testing |
E11 |
IDU |
Vibrio (including Plesiomonas shigelloides) |
Antibiotic susceptibility testing for gram negative GI pathogens |
L4 |
GBRU |
Vibrio (including Plesiomonas shigelloides) |
Identification and typing |
L4 |
GBRU |
Viral haemorrhagic fever (filoviridae, arenaviridae, Bunyaviridae) |
Serology, PCR, isolation. Please contact lab before sending samples. |
P1 |
RIPL |
VTEC O157 (See Escherichia coli) |
|
|
|
West Nile virus |
Serology, PCR
|
P1 |
RIPL |
Yeasts |
Serodiagnosis |
Y1 or Y2
|
Mycology RL |
Yellow fever virus |
Serology, PCR
|
P1 |
RIPL |
Yersinia |
Antibiotic susceptibility testing for gram negative GI pathogens |
L4 |
GBRU |
Yersinia |
Identification |
L4 |
GBRU |